0000905729-14-000217.txt : 20140630 0000905729-14-000217.hdr.sgml : 20140630 20140630160223 ACCESSION NUMBER: 0000905729-14-000217 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140630 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20140630 DATE AS OF CHANGE: 20140630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHEMICAL FINANCIAL CORP CENTRAL INDEX KEY: 0000019612 STANDARD INDUSTRIAL CLASSIFICATION: STATE COMMERCIAL BANKS [6022] IRS NUMBER: 382022454 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-08185 FILM NUMBER: 14948957 BUSINESS ADDRESS: STREET 1: 235 E MAIN ST CITY: MIDLAND STATE: MI ZIP: 48640 BUSINESS PHONE: 989-839-5350 MAIL ADDRESS: STREET 1: 235 E MAIN ST CITY: MIDLAND STATE: MI ZIP: 48640 8-K 1 chem8k_063014.htm FORM 8-K

 

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 30, 2014

Chemical Financial Corporation
(Exact Name of Registrant as
Specified in its Charter)

  Michigan
(State or Other Jurisdiction
of Incorporation)
000-08185
(Commission
File Number)
38-2022454
(IRS Employer
Identification No.)
 

 

235 E. Main Street
Midland, Michigan
(Address of Principal Executive Offices)

 

 
48640
(Zip Code)
 

Registrant's telephone number, including area code:  (989) 839-5350

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

£ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

£ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

£ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

£ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



 

 

 

Item 8.01 Other Events.

 

On June 30, 2014, Chemical Financial Corporation issued a press release regarding the closing of the sale of 375,000 shares of its common stock pursuant to the underwriters' exercise of the over-allotment option, which the Company granted in connection with its previously announced underwritten public offering of 2,500,000 shares of its common stock. A copy of this press release is attached as Exhibit 99.1 to this Form 8-K, which is here incorporated by reference.

 

Item 9.01 Financial Statements and Exhibits.
   
  (d) Exhibits:
     
    99.1 Press Release dated June 30, 2014.

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated:  June 30, 2014 CHEMICAL FINANCIAL CORPORATION
(Registrant)
     
     
    /s/ Lori A. Gwizdala
         Lori A. Gwizdala
     Executive Vice President, Chief Financial
       Officer and Treasurer

 

 

 

 

EXHIBIT INDEX

 

Exhibit Number   Document
     
99.1   Press Release dated June 30, 2014.

 

EX-99.1 2 chemex991_063014.htm PRESS RELEASE

EXHIBIT 99.1

 

For further information:

David B. Ramaker, CEO

Lori A. Gwizdala, CFO

989-839-5350

 

Chemical Financial Corporation Announces

Underwriters' Exercise of Over-Allotment Option

 

MIDLAND, Mich., June 30, 2014 — Chemical Financial Corporation (Nasdaq:CHFC) announced today the closing of the sale of 375,000 shares of its common stock pursuant to the underwriters' exercise of the over-allotment option, which the Company granted in connection with its previously announced underwritten public offering of 2,500,000 shares of its common stock. With the exercise of the over-allotment option, the Company has sold a total of 2,875,000 shares at a price of $28.00 per share to the public in the offering.

 

Keefe, Bruyette & Woods, a Stifel company, acted as the sole book-running manager in this offering. Sandler O'Neill + Partners, L.P. acted as co-manager for the offering.

 

The offering was made under the Company’s shelf registration statement filed with the Securities and Exchange Commission (SEC) on June 12, 2014, which became immediately effective.

 

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

 

The offering was made by means of a prospectus and a related prospectus supplement, copies of which may be obtained by contacting Keefe, Bruyette & Woods, Inc., Attention: Equity Capital Markets, 787 Seventh Avenue, 4th Floor, New York, NY 10019, telephone (800) 966-1559. Copies of the prospectus and related prospectus supplement may also be obtained from the SEC’s website at: www.sec.gov.

 

About Chemical Financial Corporation

 

Chemical Financial Corporation is the second largest banking company headquartered and operating branch offices in Michigan. The Company operates through a single subsidiary bank, Chemical Bank, with 157 banking offices spread over 38 counties in the lower peninsula of Michigan. At March 31, 2014, the Company had total assets of $6.34 billion. Chemical Financial Corporation's common stock trades on The NASDAQ Stock Market under the symbol CHFC and is one of the issues comprising The NASDAQ Global Select Market. More information about the Company is available by visiting the investor relations section of its website at www.chemicalbankmi.com.

 

Forward-Looking Statements

 

This news release contains various forward-looking statements. Important factors that could cause actual results to differ materially from the Company's expectations include, but are not limited to, the risk factors described in the Company's filings with the SEC, including under “Risk Factors” (including the risk factors under the heading “Risk Factors—Risks Related to the Pending Merger with Northwestern”) in the Company's Prospectus Supplement, dated June 19, 2014, and under “Risk Factors” in the Company's Annual Report on Form 10-K for the year ended December 31, 2013. These and other factors could cause a difference between an ultimate outcome and a preceding forward-looking statement.